Liu, L., Qi, S., Shao, L., Cai, J., Zeng, Q., Jiang, X., Ma, F., Lin, W.

Background
The low response rate to immunotherapy in patients with lung adenocarcinoma is primarily due to tumor immune evasion. The tumor immunosuppressive microenvironment orchestrates this evasion, yet the underlying mechanisms remain elusive. Here…